Inicio › Cáncer de páncreas › Washington › Seattle
Ensayos clínicos de Cáncer de páncreas en Seattle, WA
21 estudios para Cáncer de páncreas buscan participantes en centros de Seattle y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
ReclutandoFase 3
- University of Washington Fred Hutchinson Cancer Center, Seattle
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
ReclutandoFase 1
- Swedish Cancer Institute, Seattle
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
ReclutandoEstudio observacional
- Fred Hutchinson Cancer Center, Seattle
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
ReclutandoFase 2/3
- Virginia Mason Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
ReclutandoFase 3
- Fred Hutchison Cancer Center, Seattle
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
ReclutandoFase 3
- Investigative Site US032, Seattle
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
ReclutandoFase 3
- Virginia Mason Franciscan Health - Virginia Mason Medical Center, Seattle
- Fred Hutchinson Cancer Center - Advanced Cancer Research Group, Seattle
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
ReclutandoFase 1/2
- Fred Hutchinson Cancer Center, Seattle
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
ReclutandoFase 2
- Local Institution - 0086, Seattle
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
ReclutandoEstudio observacional
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
ReclutandoFase 2
- Virginia Mason, Seattle
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
ReclutandoFase 1
- Virginia Mason Medical Center, Seattle
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
ReclutandoFase 3
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center - Montlake, Seattle
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
ReclutandoFase 1
- Fred Hutchinson Cancer Center, Seattle
Pancreatic Cancer Early Detection Consortium
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- University of Washington, Seattle
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
ReclutandoFase 1/2
- Fred Hutchinson Cancer Center, Seattle
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
ReclutandoFase 3
- Swedish Medical Center-Ballard Campus, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- y 3 más
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
ReclutandoFase 1/2
- Virginia Mason Medical Center, Seattle
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
ReclutandoFase 1/2
- Virginia Mason Medical Center, Seattle
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
ReclutandoFase 2
- Ohio State University-Telemedicine, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Seattle
Más información sobre Cáncer de páncreas en MedlinePlus
Ensayos de Cáncer de páncreas en otras ciudades
- Houston, TX61 estudios
- New York City, NY60 estudios
- Boston, MA43 estudios
- Nashville, TN39 estudios
- Los Angeles, CA35 estudios
- St. Louis, MO33 estudios
- Arlington, VA33 estudios
- Baltimore, MD31 estudios
- San Antonio, TX31 estudios
- Philadelphia, PA26 estudios
- Tampa, FL26 estudios
- Durham, NC24 estudios
Otros estudios en Seattle
- Cáncer de pulmón de células no pequeñas53 estudios
- Cáncer (todos los tipos)49 estudios
- Cáncer de próstata42 estudios
- Leucemia mielógena aguda41 estudios
- Cáncer de seno39 estudios
- Cáncer metastásico39 estudios
- Cáncer del colon y del recto34 estudios
- Cáncer de pulmón33 estudios
- Cáncer de ovario30 estudios
- Mieloma múltiple22 estudios
- Cáncer de vejiga21 estudios
- Síndromes mielodisplásicos21 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.